BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

286 filings reported holding BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 149,815,028 shares of 193,828,463 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include Kohlberg Kravis Roberts & Co. L.P. (31,060,971 shares), VIKING GLOBAL INVESTORS LP (26,620,991 shares), VANGUARD GROUP INC (11,684,997 shares), BlackRock Inc. (9,581,729 shares), STATE STREET CORP (7,069,360 shares), Aisling Capital Management LP (6,068,125 shares), Laurion Capital Management LP (4,749,343 shares), Cormorant Asset Management, LP (4,169,179 shares), HHLR ADVISORS, LTD. (2,993,447 shares), and PICTET ASSET MANAGEMENT SA (2,532,716 shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.